4
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic

      other

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In early 2020, the COVID-19 outbreak complicated the diagnosis, treatment and rehabilitation of patients with substance use disorders and increased the risks of substance abuse and addictive behaviours, such as online gaming disorders, in the general public. Substance use disorder is a chronic recurrent brain disease characterised by strong cravings, high recurrence rates, and a high proportion of comorbidity of mental and physical disorders.1 Therefore, regular long-term therapeutic interventions are critical to preventing drug relapses while maintaining withdrawal. COVID-19 severely affects normal medical diagnoses, treatments and managements of patients with substance use disorder coupled with addiction-related behaviour. It also adversely impacts the mental state of the general public in several ways and leads to broader symptoms, including anxiety, tension and insomnia, that may increase the risk of alcohol abuse, sedative and hypnotic drug abuse, and other addictive behaviours. The State Council’s Comprehensive Team for Joint Prevention and Control of COVID-19 released a series of documents to address the importance of focusing on the prevention and control of both imported cases and internal transmission in particularly vulnerable places, such as supervision sites, pension facilities, welfare homes and mental health institutions.2 3 It is also of utmost importance to ensure the continuous, regular and effective treatment of existing patients with addiction problems, reduce the risk of drug relapse and prevent new cases of addiction during the pandemic. To this end, the Chinese Association of Drug Abuse Prevention and Treatment, the Academic Group of Drug Dependence of the Chinese Society of Psychiatry, the Academic Group of Addiction of the Chinese Society of Psychosomatic Medicine, and the Specialty Committee of Addiction Medicine of the Chinese Psychiatrist Association jointly published an expert consensus to inform the public with proper guidance to prevent addiction and provide professional diagnoses, treatment and management of these addictions. Since these issues are faced by various groups of people, we addressed these problems based on different populations. Practical difficulties faced by the general population and patients with addiction problems during the pandemic COVID-19 has caused a serious and comprehensive impact on the public. The dual stress fomented by ‘confronting a pandemic’ and ‘isolation at home’ negatively impacts mental health to various degrees. Those affected often manifest symptoms such as tension, worry, fear, depression and distress. If not properly vented, these emotional problems can increase the risk of substance abuse and gaming disorders.4 Studies have shown that when stressed, abstinent patients with substance use disorder are more likely to have negative emotions and are preconditioned to return to previous behavioural patterns as a coping mechanism. For example, they relieve anxiety, depression or insomnia through excessive use of tobacco, alcohol or even drugs, all of which lead to relapses or exacerbations of existing conditions.5–7 For current patients with addiction problems, the amount and frequency of substance use are amplified when they encounter stressful situations. Therefore, the occurrence, development, addiction relapse and the state of stress may mutually influence and aggravate each other during the pandemic. This in turn increases the aggregated risk. In addition to mutual influences, daily medical treatments for patients with addiction problems are also affected to varying degrees based on restrictive isolation policies and delivery inconveniences during a pandemic. For instance, patients who require methadone maintenance therapy may not be able to receive methadone in a timely manner, and this may increase the risk of psychobehavioural problems and potential relapse. Addiction problems and prevention advice that the general public should focus on during the pandemic The COVID-19 pandemic is a serious public crisis that has interactive susceptibility with addictive behaviours. Stressful circumstances can increase the risk of addictive behaviour; therefore, it is important to prevent the occurrence of substance use and other addictive behaviours during difficult situations, such as this pandemic. Addiction problems As mentioned, during the pandemic—especially during long periods of isolation—several kinds of stress may lead to negative emotions and related maladaptive coping styles. Among the types of addictive substances and behaviours that warrant special attention are abuse of alcohol or sedative hypnotics and compulsive internet gaming. Alcohol abuse As a central nervous system depressant, alcohol is widely used by the general public. In addition to social drinking, many individuals imbibe as a form of self-treatment, such as relief for anxiety or depression, or to help them sleep. However, long-term excessive drinking often leads to alcohol abuse or dependence and can cause a series of physical and mental health problems. During any pandemic, there is an increased risk of fomenting disturbing feelings or aggravating existing negative emotions in patients with addiction problems as well as in the general public. Some will attempt to confront their problems by drinking. This in turn increases the risk of alcohol abuse or eventual addiction. In addition, if alcohol-dependent patients suddenly stop drinking, they may experience severe withdrawal symptoms which could be life-threatening, such as delirium tremens, epileptic seizures and electrolyte imbalance. Therefore, at-risk persons should avoid drinking as a means to cope with emotional problems or insomnia, and patients with alcohol dependence must be encouraged to remain abstinent when isolated at home. Sedative hypnotic abuse There are many types of sedative and hypnotic drugs, most of which include antianxiety remedies that can mitigate negative emotions caused by tension, anxiety and fear. Sedative hypnotics offer mild and generally positive sedative effects when taken in small dosages. Larger dosages tend to induce sleep. As a pandemic spreads, the number of individuals with anxiety and insomnia likewise increases gradually, as do the risks and potential addictions. Some also use sedatives and hypnotic drugs combined with alcohol to accentuate the effects, and this often results in more serious negative consequences. Therefore, the preferred recommendations for relieving anxiety and insomnia are non-pharmaceutical therapies such as relaxation practices, t’ai chi and yoga. If pharmacotherapy is necessary for acute cases, sedative and hypnotic drugs should only be used under the guidance of professional doctors rather than self-administration. Overuse of games and the internet Gaming disorder is primarily found in adolescents, while excessive internet use is seen in all ages.8 9 With the popularity of the internet and smartphones, there are increased risks of addiction to internet games, short videos, online graphic novels and comics, and even internet gambling, online pornography and other disruptive content. For teenagers, the influencing factors generally include changes to their daily routines and home studies during the pandemic period. Some of the most prevalent characteristics of adolescents are impulsiveness and curiosity. For young and middle-aged adults, the main factors are disruptive changes to their living and working spaces, as well as interruptions to their daily social activities. The elderly are adversely affected by changes to their daily rhythm. Interventions to prevent internet and gaming addictions should be tailored to the specific characteristics of each age group, including regular rest and alternative forms of enriching one’s daily life by developing healthy interests and hobbies. Prevention and suggestions During the COVID-19 pandemic, related work can be conducted in accordance with the different risk levels. General population The general public should plan their lives, maintain healthy lifestyles and conform to proper daily routines during isolation periods. Regular sleeping and eating combined with moderate exercise provide individuals with sufficient energy to manage the daily requirements of work and life. Maintain communication with friends and distant family members through email, telephone and social apps such as WeChat.10 Those who are physically and mentally capable should make full use of available resources to learn simple, practical and evidence-based self-adjustment methods (eg, muscle relaxation training, mindfulness, negative emotion recognition and coping mechanisms). Harmful coping strategies should be avoided, such as reliance on tobacco, alcohol or other addictive substances. Parents can also use digital management software to restrict their children’s phone usage to reduce the potential risks of communicating with anonymous or aggressive persons. Expanding public knowledge on addiction is an important way to prevent addictive behaviours. Professionals should make use of various media, including published articles, animation, audio and broadcasts, to enhance the accessibility of informative content for different groups. Key population Groups with higher risks of addiction include persons with sleep disorders, smokers, drinkers, adolescents, individuals who are particularly susceptible to stress or have specific personality characteristics (eg, impulsiveness, curiosity), people who to date have abstained from addictive behaviours, patients with mental diseases and so on.11 12 According to the changes to addictive behaviours after previous public health or other major stress events, training related to adaptive coping skills should be available for high-risk groups. This includes maintaining healthy lifestyles, stress management, coping to a reasonable degree with negative emotions and seeking psychological assistance, all of which can serve to identify additional risk factors as early as possible and prevent addiction through further intervention. Psychological intervention hotlines and outpatient services that screen for addictive behaviours should be widely available to improve early detection and intervention. In addition to the aforementioned high-risk groups, visitors should also be asked about the following problematic characteristics that may manifest during a pandemic: whether their dosages and frequency of substance use have increased compared with previous events; whether they have been able to quit again; whether they now rely on any addictive substances to relieve negative emotions; and whether they experienced withdrawal symptoms after reducing or quitting substance use. Patients who are known to have elevated risk or have the aforementioned characteristics should accept brief interventions or agree to further professional evaluations. Those who are diagnosed with substance use disorder should be transferred to specialised treatment institutions that provide addiction medicine to receive timely treatment. Advice for patients with addiction problems and their families or guardians Family support plays an important role in preventing relapses of patients with addiction problems. Family members can reduce patient cravings and prevent regression by stabilising family relationships while helping them reduce negative emotions and cope with high-risk factors. Patients with addiction problems and their families should pay special attention to all of the followings: Understand and pay close attention to emotions Patients and their families can learn to understand their emotional states using appropriate psychometric assessment tools. Furthermore, they can also receive training to adjust and relieve negative emotions through mindfulness, meditation, relaxation training and other methods. Patients and their families should realise that mild tension and anxiety during stressful situations are considered normal reactions that in turn can help them remain alert and mitigate their nervousness. Once uncontrolled negative emotions begin to have a significant impact on daily life and work, patients should request an online consultation or visit a professional institution for appropriate treatment. Build one’s own social support system Talking with others can effectively help individuals relieve tension and anxiety. Therefore, the family members of patients with addiction problems can establish their own social support systems. Family members and close friends should communicate more frequently and adopt methods of ‘healing in groups’ to help each other solve problems encountered during a pandemic. If this method does not effectively solve the problem and bouts of severe insomnia, depression or anxiety continue to occur, the best advice is to request a phone consultation with a mental health institution. If necessary in severe cases, the person should visit a psychiatric emergency department to receive appropriate treatment. Proper management of addictive substances: strengthening observation and support for patients During a pandemic, negative emotions may increase substance abuse. Family members should carefully monitor all addictive substances at home, including alcohol and sedative hypnotics. For patients with drug addiction, family members should control all finances to ensure that the patient is unable to acquire drugs. After using addictive substances, patients with addiction problems often change their diets, sleep patterns and daily routines. Therefore, these often serve as indirect indicators that the patient has suffered a relapse simply by observing changes in their daily life. Proper responses to withdrawal symptoms and relapses Patients who are currently using addictive substances, those who have been using alcohol and sedative hypnotics for a long time, or patients who are receiving drug maintenance therapy may experience withdrawal symptoms as a result of the pandemic’s impact. When this occurs, they should seek immediate help from professional institutions. When a patient relapses for the first time, family members should stabilise their emotions and avoid casting excessive blame on the patient. At the appropriate time, they can analyse the causes and discuss countermeasures together with the patient to avoid further recurrences. If the patient has had repeated relapses, they should be observed closely, advised patiently and escorted to a medical institution for treatment as soon as possible once the pandemic is under control or when the conditions are considered safe enough to visit public facilities. If the relapse has resulted in a physical or psychiatric emergency, the patient should be taken to a professional medical institution for emergency treatment. Actively acquire knowledge related to COVID-19 and strengthen self-protection Patients and families can acquire scientific knowledge, learn the protective measures for COVID-19 from official media sources, and control the quality of information to avoid negative effects caused by false or excessive information. At the same time, social resources, including community portals, media outlets and hotlines, can be used to alleviate negative emotions and concerns. Suggestions for rehabilitation treatment centres At present, China’s intervention institutions for drug use and addiction include primarily compulsory isolation drug rehabilitation institutions, voluntary rehabilitation facilities, methadone maintenance treatment clinics and community treatment centres. During a pandemic, these institutions should take preventive measures against COVID-19 while ensuring the continuity of treatment and rehabilitation to the greatest possible extent. In response to practical difficulties, the various types of institutions should offer corresponding solutions whenever possible. Drug treatment and rehabilitation institutions Isolation and detoxification agencies of the public security and judicial systems are all stringently managed. Limitations to rehabilitation activities, family visits, communication and related problems may cause patients to experience emotional stress with corresponding physical symptoms during a pandemic. In severe cases, negative effects, self-injury or even psychotic symptoms may occur. At the same time, appropriate site management and services may be hindered. Possible actions to address these circumstances include the following: Patients can be sent outdoors (playground) or to a rehabilitation treatment room in groups, subject to safety regulations Through reasonable planning and organisation, participant activity spaces can be amplified based on the premise that closed isolation may have been a root cause of their negative behaviour. In these spaces, appropriate recreation can be offered, such as yoga, mindfulness exercises, aerobics, t’ai chi, baduanjin and other sports that have been found to reduce anxiety, irritability and stress. For these rehabilitation activities, individuals should maintain social distancing of more than 1 metre, wear masks and pay attention to disinfection and ventilation in the activity areas. Enhance health education in rehabilitation institutes Posters, missionary videos and health education lectures can be used to educate patients about COVID-19 in a venue. This can help improve patients’ ability to identify diseases, understand prevention and control techniques, and reduce the risk of negative emotions caused by inadequate knowledge or misunderstanding. Strengthen communication with family members by allowing family calls If possible, the venue should provide family telephones to allow patients to communicate via telephone or video so they are kept abreast of their situation and receive care and encouragement from family members, thereby alleviating potential negative emotions. Receive help from specialist agencies when necessary Most psychological problems suffered by patients can be resolved by using online consultation services provided by various medical institutions or other social services. However, for patients with more severe emotional disorders or persistent hallucinations, impulsive violence or other detrimental behaviours, appropriate medical treatment should be sought based on the evaluation of a professional physician. Commonly used medications include benzodiazepines, antidepressants, mood stabilisers or antipsychotics. Methadone maintenance treatment facilities For patients receiving methadone maintenance treatment, the dual effects of opioid addiction and pandemic stress may leave patients more prone to mental and psychological distress. In addition, certain circumstances will make treatment of such patients difficult, including isolation management, fear of being infected when going out to take medication, conscious avoidance of treatment and complications of the medication process under pandemic conditions. Open management and treatment in the community may also increase the risk of relapse. Possible actions to address these issues include the followings: Provide a safer medical environment and alleviate patient concerns about infection during daily medication Methadone maintenance treatment sites should manage the environment of the entire facility, maintain clean and ventilated spaces, disinfect regularly, and ensure that all medical personnel adhere to personal protective measures. Patients should be assisted when taking medicine in groups at clinics, and long line-ups should be avoided. Patients receiving medication should be required to wear a mask and cooperate during body temperature measurements. They should be questioned about any related clinical symptoms and their epidemiological history, such as cough, shortness of breath, fatigue, diarrhoea and so on. Those with any abnormalities should be reported to the appropriate departments for further treatment. Pay more attention to the education and prevention of COVID-19 and screening evaluations To reduce the risk of cross-infection, remote networks and psychological interventions by telephone can be implemented. If a patient’s mental and behavioural problems have affected regular daily life and social functioning, the patient should be referred to a mental health institution for further diagnosis and treatment in a timely manner subject to local safety measures. Maintain the stability of the treatment plan and prevent additional substance addiction During a pandemic, care should be taken before avoiding or adjusting any methadone dose to prevent withdrawal symptoms or fluctuating conditions that increase the difficulty of treatment. Combined with local methadone maintenance treatment policies and outpatient management regulations, to ensure safety, patients in stable condition with good compliance records can be considered for methadone take-home services or provided with alternative treatments such as Suboxone to minimise risks of cross-infection. Voluntary drug treatment agencies Voluntary detoxification is an important part of our drug rehabilitation system. At present, the domestic voluntary drug treatment institutions encompass primarily the addiction specialty departments of psychiatric hospitals and independent drug treatment hospitals. In addition to providing diagnoses and treatment services for drug dependence and related disorders, they also conduct outpatient and inpatient treatment of issues related to substance addiction, including alcohol and sedative hypnotics and behavioural addiction. During this COVID-19 pandemic, the normal diagnoses and treatment of patients with substance and behavioural dependence throughout the community are inevitably affected. Strengthen departmental coordination and optimise the treatment model The goal should be to establish sound coordination mechanisms with public security agencies, comprehensive medical institutions, community drug treatment and rehabilitation agencies, drug maintenance and treatment agencies, and other addiction-related units. Also important is the fortification of contacts and liaisons with consultants. Given the actual situation in any local area, it is necessary to refine the work content and procedures to further ensure that persons with substance abuse and behavioural problems can receive prompt medical treatment, timely referrals and hospitalisation when necessary. Strengthen publicity and expand the coverage of treatment and prevention of addictive diseases Voluntary detoxification agencies should not only ensure routine diagnoses and treatment but also assume the responsibility of preventing addictive behaviours caused by serious public health events. Measures like science popularisation and professional training to assist the general population’s ability to improve self-screening for substance abuse and behavioural problems also benefit the community medical institutions and non-addiction-related professional medical personnel in their attempts to identify addiction-related disorders and to expand the coverage of prevention and treatment services. The screening of addictive substance use, prevention and education for clinic patients, as well as the timely identification, diagnosis and treatment of related mental and behavioural problems may all occur under stressful conditions. Follow-up sessions can be conducted through appropriate communication channels (eg, phone, email, WeChat and so on). Strengthen internal management to ensure treatment effectiveness It is necessary to improve the management of facilities and all hospitalised patients, to adopt appropriate measures to isolate and prevent infection from spreading among both the hospital staff and patients, and to eliminate the introduction of possible sources of out-of-hospital external infections. Also important is the dissemination of related medical knowledge and the provision of pharmaceutical and/or psychological interventions to treat mental and psychological problems such as stress, negative feelings and insomnia. Also, the optimisation of outpatient appointment schedules would enable patients to visit doctors in an orderly manner and prevent infection risks caused by too many persons gathering in confined spaces. Telemedicine services can also be provided to discharged patients by telephone, online consultation and other methods to enhance continuous service quality. Management of comorbid COVID-19 and/or other diseases in patients with addiction problems Patients with addiction problems often suffer from several physical and mental illnesses. This substantially increases the difficulty of treatment once a patient contracts COVID-19. The treatment of comorbid physical and mental illnesses often requires the deployment of alternative addiction treatments. Suspected or actual COVID-19 infection in patients with addiction problems Patients with addiction problems who are either suspected of being infected or are infected with COVID-19 should be isolated immediately for a predetermined period. Isolation, treatment and recovery management should be provided in accordance with the stipulated requirements for suspected or infected patients. Special attention should be paid when asking patients about previous and current substance abuse, withdrawal symptoms previously experienced, and other physical diseases. Addiction professionals should be invited to join treatment groups, thereby allowing general physicians and these specialists to jointly formulate the most appropriate treatment plans. When controlling physical diseases, medical teams should treat the symptoms generated by withdrawal from addictive substances. Patients suffering from the dual effects of COVID-19 and withdrawal may complicate the disease and increase the difficulty of treatment. Therefore, the patient’s vital signs should be closely monitored and variances should be treated promptly. Psychosocial interventions should also be provided during treatment. Other comorbid physical or mental diseases in patients with addiction problems Often that patients with addiction problems have other comorbid physical or mental diseases. Reports show that about 50%–70% of patients with addiction problems suffer from other mental illnesses, and 20%–50% of patients with other mental illnesses also suffer from substance use disorders. Also, long-term use of psychoactive substances may lead to malnutrition, low immune function and a higher risk of contracting other physical diseases.13 Practical difficulties during this pandemic have inconvenienced patients from receiving timely medical treatment, and this in turn may lead to increased risk of addictive substance use. Therefore, more attention should be paid to the physical and mental conditions of patients with comorbid conditions. If treatments not involving drugs are ineffective in coping with negative emotions and/or exacerbations of physical illnesses, patients should be instructed to seek professional treatment as soon as possible. In sum, according to the theory of stress-facilitated addictive behaviours when coupled with environmental and other restrictions, the prevalence of patients with addiction-related disorders may increase during a pandemic, while existing patients may exacerbate their poor condition or even relapse,14 thus posing greater challenges for the healthcare personnel. This article provides a summary of the common addictive behaviour problems that may occur or worsen among the general population and patients with addiction problems during a pandemic and proposes possible intervention methods. We hope to use this research as a foundation to further explore a set of effective prevention and treatment methods for addiction that are bound to be necessary during future major public health crises in order to prepare and benefit the general population.

          Related collections

          Most cited references9

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations

          The Coronavirus Disease 2019 (COVID-19) epidemic emerged in Wuhan, China, spread nationwide and then onto half a dozen other countries between December 2019 and early 2020. The implementation of unprecedented strict quarantine measures in China has kept a large number of people in isolation and affected many aspects of people’s lives. It has also triggered a wide variety of psychological problems, such as panic disorder, anxiety and depression. This study is the first nationwide large-scale survey of psychological distress in the general population of China during the COVID-19 epidemic.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            2019-nCoV epidemic: address mental health care to empower society

            A novel coronavirus (2019-nCoV) has been identified as originating in Wuhan, Hubei Province, China. It has widely and rapidly spread in China and several other countries, causing an outbreak of acute infectious pneumonia. According to the official website of the National Health Commission, 1 as of Feb 4, 2020, 24 324 people have been confirmed to have a 2019-nCoV infection and 490 deaths have resulted from 2019-nCoV in 31 provinces in mainland China. 1 16 678 confirmed cases were in Hubei province. 2 Nearly 160 cases of 2019-nCoV have been detected and confirmed in southeast Asia (Thailand, Singapore, Malaysia, Vietnam, Philippines, and Cambodia), east Asia (Japan and Korea), south Asia (India, Nepal, and Sri Lanka), western Asia (United Arab Emirates), Europe (Germany, France, Italy, UK, Russia, Finland, Spain, and Sweden), North America (USA and Canada), and Australia. 3 Approximately 13% of people with confirmed 2019-nCoV infection are reported to have severe respiratory symptoms, 2% have died, and 4% have been cured. 1 Human-to-human transmission is occurring, and WHO has recommended limiting human-to-human transmission by reducing secondary infections among close contacts and health-care workers, preventing transmission amplification events, and preventing further international spread.3, 4 The outbreak of 2019-nCoV in China has caused public panic and mental health stress. The increasing number of patients and suspected cases, and the increasing number of outbreak-affected provinces and countries have elicited public worry about becoming infected. The unpredictable future of this epidemic has been exacerbated by myths and misinformation, often driven by erroneous news reports and the public's misunderstanding of health messages, thus causing worry in the population. Further travel bans and some executive orders to quarantine travellers during the Spring Festival holiday might have generated public anxiety while trying to contain the outbreak. The medical health-care workers who are caring for individuals who are either severely ill, feel scared, or experiencing bereavement are themselves exposed to trauma. Health-care workers are also at risk of getting infected, and they carry a large burden in the clinical treatment and public prevention efforts in Chinese hospitals and community settings. The challenges and stress they experience could trigger common mental disorders, including anxiety and depressive disorders, and posttraumatic stress disorder, 5 which in turn could result in hazards that exceed the consequences of the 2019-nCoV epidemic itself. To efficiently cope with the 2019-nCoV outbreak, the Chinese Government has implemented rapid and comprehensive public health emergency interventions. To date, all of the 31 provincial-level regions in mainland China with confirmed 2019-nCoV cases have activated so-called level 1 public health emergency responses (ie, the highest level of emergency public health alerts and responses within the national public health management system). 6 The provincial governments are responsible for organising, coordinating, and handling all emergency public health treatments, disclosing information, and gathering emergency materials and facilities under the guidance of the State Council. For health-care sectors, in addition to public health interventions, dealing with public psychological barriers and performing psychological crisis intervention is included in the level 1 response. The National Health Commission has released guidelines for local authorities to promote psychological crisis intervention for patients, medical personnel, and people under medical observation during the 2019-nCoV outbreak. 7 Peking University is preparing a mental health handbook for the public that describes how to deal with stress and other psychological problems occurring due to the outbreak of 2019-nCoV. 8 The Chinese Government strives to improve the public's awareness of prevention and intervention strategies by providing daily updates about surveillance and active cases on websites and social media. Increasingly, psychologists and psychiatrists use the internet and social media (eg, WeChat, Weibo, etc) to share strategies for dealing with psychological stress. For example, experts from Peking University Sixth Hospital made six suggestions for the public to cope with mental stress. 9 These included assessing the accuracy of information disclosed, enhancing social support systems (eg, families and friends), eliminating stigma associated with the epidemic, maintaining a normal life under safe conditions, and using the psychosocial service system, particularly telephone-based and internet-based counselling for health-care staff, patients, family members, and the public. Numerous psychiatric hospitals, psychological counselling centres, and psychology departments within universities have launched specialised hotlines to provide psychological counselling services for people in need. 7 We believe that including mental health care in the national public health emergency system will empower China and the world during the campaign to contain and eradicate 2019-nCoV.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Alcohol disrupts sleep homeostasis.

              Alcohol is a potent somnogen and one of the most commonly used "over the counter" sleep aids. In healthy non-alcoholics, acute alcohol decreases sleep latency, consolidates and increases the quality (delta power) and quantity of NREM sleep during the first half of the night. However, sleep is disrupted during the second half. Alcoholics, both during drinking periods and during abstinences, suffer from a multitude of sleep disruptions manifested by profound insomnia, excessive daytime sleepiness, and altered sleep architecture. Furthermore, subjective and objective indicators of sleep disturbances are predictors of relapse. Finally, within the USA, it is estimated that societal costs of alcohol-related sleep disorders exceeds $18 billion. Thus, although alcohol-associated sleep problems have significant economic and clinical consequences, very little is known about how and where alcohol acts to affect sleep. In this review, we have described our attempts to unravel the mechanism of alcohol-induced sleep disruptions. We have conducted a series of experiments using two different species, rats and mice, as animal models. We performed microdialysis, immunohistochemical, pharmacological, sleep deprivation and lesion studies which suggest that the sleep-promoting effects of alcohol may be mediated via alcohol's action on the mediators of sleep homeostasis: adenosine (AD) and the wake-promoting cholinergic neurons of the basal forebrain (BF). Alcohol, via its action on AD uptake, increases extracellular AD resulting in the inhibition of BF wake-promoting neurons. Since binge alcohol consumption is a highly prevalent pattern of alcohol consumption and disrupts sleep, we examined the effects of binge drinking on sleep-wakefulness. Our results suggest that disrupted sleep homeostasis may be the primary cause of sleep disruption observed following binge drinking. Finally, we have also shown that sleep disruptions observed during acute withdrawal, are caused due to impaired sleep homeostasis. In conclusion, we suggest that alcohol may disrupt sleep homeostasis to cause sleep disruptions.
                Bookmark

                Author and article information

                Journal
                Gen Psychiatr
                Gen Psychiatr
                gpsych
                gpsych
                General Psychiatry
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2517-729X
                2020
                8 July 2020
                : 33
                : 4
                : e100252
                Affiliations
                [1 ]departmentDrug Abuse Treatment Department , Shanghai Mental Health Center , Shanghai, China
                [2 ]departmentDrug Abuse Treatment Department , Affiliated Brain Hospital of Guangzhou Medical University , Guangzhou, Guangdong, China
                [3 ]Shanghai Mental Health Center , Shanghai, China
                [4 ]departmentMental Health Institute, Second Xiangya Hospital , Central South University , Changsha, Hunan, China
                [5 ]departmentMental Health Institute , Second Xiangya Hospital , Changsha, Hunan, China
                [6 ]Peking University Sixth Hospital , Beijing, China
                [7 ]Peking University School of Basic Medical Sciences , Beijing, China
                [8 ]departmentThe Affiliated Brain Hospital , Guangzhou Medical University , Guangzhou, Guangdong, China
                [9 ]departmentMental Health Institute , Sichuan University West China Hospital , Chengdu, Sichuan, China
                [10 ]departmentDrug Abuse Treatment Department , Beijing Huilongguan Hospital , Beijing, China
                [11 ]departmentDrug Abuse Treatment Department , Beijing An Ding Hospital , Beijing, China
                [12 ]departmentDrug Abuse Treatment Department , Wuhan Mental Health Center , Wuhan, Hubei, China
                [13 ]departmentDrug Abuse Treatment Department , Brain Hospital of Hunan Province , Changsha, China
                [14 ]Huzhou Third People's Hospital , Huzhou, Zhejiang, China
                [15 ]departmentDrug Abuse Treatment Department , Ningbo University Medical School , Ningbo, Zhejiang, China
                [16 ]departmentDrug Abuse Treatment Department , Xinxiang Medical University Affiliated Second Hospital , Xinxiang, Henan, China
                [17 ]Xinjiang Medical University Affiliated First Hospital , Urumqi, Xinjiang, China
                [18 ]departmentMental Health Department , First Affiliated Hospital of Harbin Medical University , Harbin, Heilongjiang, China
                [19 ]departmentMental Health Department , Shandong Province Ankang Hospital , Jining, Shandong, China
                [20 ]Huayou Health Care Center , Beijing, China
                [21 ]departmentDrug Abuse Treatment Department , Shenzhen Kangning Hospital , Shenzhen, Guangdong, China
                [22 ]departmentDrug Abuse Treatment Department , Shandong Mental Health Center , Jinan, China
                Author notes
                [Correspondence to ] Dr Min Zhao; drminzhao@ 123456smhc.org.cn ; Professor Wei Hao; weihao57@ 123456163.com

                JD and TL are joint first authors.

                Author information
                http://orcid.org/0000-0002-4551-043X
                Article
                gpsych-2020-100252
                10.1136/gpsych-2020-100252
                7358097
                ec9ae8ee-ef84-4048-8e56-05acf302d1fb
                © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

                History
                : 23 April 2020
                : 30 May 2020
                : 04 June 2020
                Funding
                Funded by: Shanghai Academic Research Leader;
                Award ID: 17XD1403300
                Funded by: Shanghai Intelligent Engineering Technology Research Center for Addiction and rehabilitation;
                Award ID: 19DZ2255200
                Funded by: Shanghai Key Laboratory of Psychotic Disorders;
                Award ID: 13DZ2260500
                Funded by: Shanghai Clinical Research Center for Mental Health;
                Award ID: 19MC1911100
                Funded by: Shanghai Intelligent Engineering Technology Research Center for Addiction and Rehabilitation;
                Award ID: 19DZ2255200
                Categories
                Forum
                1506
                2474
                Custom metadata
                unlocked

                psychotic disorders,public health administration

                Comments

                Comment on this article